Infiltration of tumours by macrophages and dendritic cells: Tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Novartis Foundation Symposium

Volumn 256, Issue , 2004, Pages 137-145

  Mantovani, Alberto ^a,b   Sozzani, Silvano ^a,c   Locati, Massimo ^b   Schioppa, Tiziana ^a   Saccani, Alessandra ^a   Allavena, Paola ^a   Sica, Antonio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL MOTION; DENDRITIC CELL; HUMAN; IMMUNOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; NEOPLASM; PATHOLOGY; PHAGOCYTE; PHYSIOLOGY; REVIEW;

ANIMALS; CELL MOVEMENT; DENDRITIC CELLS; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; NEOPLASMS; PHAGOCYTES;

EID: 2142662869     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (37)

1. Adini A, Kornaga T, Firoozbakht F, Benjamin LE 2002 Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 62: 2749-2752
2. Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A 2000 The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev 177:141-149
3. Balkwill F, Mantovani A 2001 Inflammation and cancer: back to Virchow? Lancet 357:539-545
4. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmè D 1996 Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the flt-1/VEGF receptor. Blood 87:3336-3343
5. Bergers G, Brekken R, McMahon G et al 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744
6. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P 2003 L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 24:302-306
7. Chaux P, Moutet M, Faivre J, Martin F, Martin M 1996 Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab Invest 74:975-983
8. Coussens LM, Werb Z 2001 Inflammatory cells and cancer: think different! J Exp Med 193:F23-F26
9. Coussens LM, Tinkle CL, Hanahan D, Werb Z 2000 MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490
10. Dhawan P, Richmond A 2002 A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem 277: 7920-7928
11. DiNapoli MR, Calderon CL, Lopez DM 1996 The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med 183:1323-1329
12. Duyndam MC, Hilhorst MC, Schluper HM et al 2002 Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. Am J Pathol 160:537-548
13. Goerdt S, Orfanos CE 1999 Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10:137-142
14. Haghnegahdar H, Du J, Wang D et al 2000 The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol 67:53-62
15. Ibe S, Qin Z, Schuler T, Preiss S, Blankenstein T 2001 Tumor rejection by disturbing tumor stroma cell interactions. J Exp Med 194:1549-1559
16. + regulatory T cells. J Exp Med 194:847-853
17. Kambayashi T, Alexander HR, Fong M, Strassmann G 1995 Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol 154:3383-3390
18. Kim J, Modlin RL, Moy RL et al 1995 IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 155:2240-2247
19. Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T 2001 Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 61:7305-7309
20. Lin EY, Nguyen AV, Russell RG, Pollard JW 2001 Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
21. Locati M, Deuschle U, Massardi ML et al 2002 Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 168:3557-3562
22. Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS 1999 Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 163:6251-6260
23. Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A 1995 TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 155:4926-4932
24. Mantovani A 1999 The chemokine system: redundancy for robust outputs. Immunol Today 20:254-257
25. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L 1992 The origin and function of tumor-associated macrophages. Immunol Today 13:265-270
26. Mantovani A, Sozzani P, Locati D, Allavena P, Sica A 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol, in press
27. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM2000 M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164:6166-6173
28. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR 1993 Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91:2194-2206
29. Nowicki A, Szenajch J, Ostrowska G et al 1996 Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1- dependent macrophages in formation of tumor stroma. Int J Cancer 65:112-119
30. Rollins B 1999 Chemokines and cancer, Humana Press, Totowa, NJ
31. Scarpino S, Stoppacciaro A, Ballerini F et al 2000 Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cell to release chemokines active in recruiting dendritic cells. Am J Pathol 156:831-837
32. Schutyser E, Struyf S, Proost P et al 2002 Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem 277:24584-24593
33. Sica A, Saccani A, Borsatti A et al 1997 Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes . J Exp Med 185:969-974
34. Sica A, Saccani A, Bottazzi B et al 2000a Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J Immunol 164:733-738
35. Sica A, Saccani A, Bottazzi B et al 2000b Autocrine production of IL-10 mediates defective IL-12 production and NF-kappaB activation in tumor-associated macrophages. J Immunol 164:762-767
36. Stein M, Keshav S, Harris N, Gordon S 1992 Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176:287-292
37. Yang J, Richmond A 2001 Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res 61:4901-4909